Apixaban Dosing Patterns Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation Receiving Dialysis: A Retrospective Cohort Study

Effect of Rivaroxaban or Apixaban in Atrial Fibrillation Patients with Stage 4–5 Chronic Kidney Disease or on Dialysis

(2021) Chen Chen et al.   CARDIOVASCULAR DRUGS AND THERAPY

Pattern and Impact of Off-label Underdosing of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Who are Indicated for Standard Dosing

(2020) Min Soo Cho et al.   AMERICAN JOURNAL OF CARDIOLOGY

Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation

(2020) James B. Wetmore et al.   STROKE

Initiator Types and the Causal Question of the Prevalent New User Design: A Simulation Study

(2020) Michael Webster-Clark et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis

(2020) Lai-Chu See et al.   CARDIOVASCULAR DRUGS AND THERAPY

Risk of hospitalised bleeding in comparisons of oral anticoagulant options for the primary treatment of venous thromboembolism

(2019) Pamela L. Lutsey et al.   BRITISH JOURNAL OF HAEMATOLOGY

The Role of Vitamin K in Vascular Calcification

(2019) Mario Cozzolino et al.   ADVANCES IN CHRONIC KIDNEY DISEASE

Factors Associated With Withdrawal From Maintenance Dialysis: A Case-Control Analysis

(2018) James B. Wetmore et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Outcomes Associated with Apixaban Use in End-Stage Kidney Disease Patients with Atrial Fibrillation in the United States

(2018) Konstantinos C. Siontis et al.   CIRCULATION

Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

(2018) Mintu P Turakhia et al.   EUROPEAN HEART JOURNAL

Apixaban Pharmacokinetics at Steady State in Hemodialysis Patients

(2017) Thomas A. Mavrakanas et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis

(2015) K. E. Chan et al.   CIRCULATION

Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies

(2015) Peter C. Austin et al.   STATISTICS IN MEDICINE

Worth the Weight: Using Inverse Probability Weighted Cox Models in AIDS Research

(2014) Ashley L. Buchanan et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Atrial fibrillation and risk of stroke in dialysis patients

(2013) James B. Wetmore et al.   ANNALS OF EPIDEMIOLOGY

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

A tutorial on propensity score estimation for multiple treatments using generalized boosted models

(2013) Daniel F. McCaffrey et al.   STATISTICS IN MEDICINE

The prevalence of and factors associated with chronic atrial fibrillation in Medicare/Medicaid-eligible dialysis patients

(2011) James B. Wetmore et al.   KIDNEY INTERNATIONAL

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

An automated database case definition for serious bleeding related to oral anticoagulant use

(2011) Andrew Cunningham et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation

(2009) Alan S. Go et al.   CIRCULATION

Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited

(2009) Timothy Watson et al.   LANCET

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE